SCHEMBL12422138

SCHEMBL12422138

Cc1ccc2nc(-c3ccc(NC(=O)c4ccc([18F])nc4)cc3)cn2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.64
RAB9A P51151 7/20 0.64
NPC1 O15118 6/20 0.64
KDM4E B2RXH2 5/20 0.64
ALDH1A1 P00352 5/20 0.64
HPGD P15428 4/20 0.64
MCHR1 Q99705 6/20 0.55
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
PAX8 Q06710 2/20 0.51
MITF O75030 1/20 0.51
KDM5A P29375 1/20 0.51
KDM5C P41229 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 3/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 3/20 0.48
NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2195616 1.00 SMN1; SMN2 (0.64) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL2193327 0.88 RAB9A (0.65) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL16623339 0.87 NPC1 (0.74) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL1999354 0.87 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL1995023 0.86 RAB9A (0.60) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL2192968 0.85 SMN1; SMN2 (0.64) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL2194530 0.84 NPC1 (0.70) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL2194816 0.84 NPC1 (0.70) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL2194815 0.83 NPC1 (0.65) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1
SCHEMBL2195549 0.83 NPC1 (0.65) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES MAPT, PRNP, MAP4 SMN1; SMN2 1022/4885RAB9A 2622/4885NPC1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.